Dhananjay B. Patankar
Nessuna posizione attualmente
Profilo
Dhananjay B.
Patankar worked as the Head of Biopharmaceutical Development at Syngene International Ltd.
and as the Chief Operations & Technology Officer at Intas Biopharmaceuticals Ltd.
He holds a doctorate degree from the University of Utah and a graduate degree from the Indian Institute of Technology Bombay.
Precedenti posizioni note di Dhananjay B. Patankar
| Società | Posizione | Fine |
|---|---|---|
| SYNGENE INTERNATIONAL LIMITED | Corporate Officer/Principal | 01/06/2022 |
Intas Biopharmaceuticals Ltd.
 Intas Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Intas Biopharmaceuticals Ltd. researches and develops pharmaceutical products. It manufactures Pegylated GCSF in India and markets under the brand name NEUPEG. The company was founded in 2000 and is headquartered in Ahmedabad, India. | Direttore operativo | - |
Formazione di Dhananjay B. Patankar
| University of Utah | Doctorate Degree |
| Indian Institute of Technology Bombay | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SYNGENE INTERNATIONAL LIMITED | Commercial Services |
| Aziende private | 1 |
|---|---|
Intas Biopharmaceuticals Ltd.
Intas Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Intas Biopharmaceuticals Ltd. researches and develops pharmaceutical products. It manufactures Pegylated GCSF in India and markets under the brand name NEUPEG. The company was founded in 2000 and is headquartered in Ahmedabad, India. | Health Technology |
- Borsa valori
- Insiders
- Dhananjay B. Patankar
